Opportunity Information: Apply for PAR 09 056

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Improving Intervention Possibilities forCommunication Disorders (R21/R33)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173 Research Related to Deafness and Communication Disorders.
  • This funding opportunity was created on Dec 19, 2008 and posted on Dec 19, 2008.
  • Applicants must submit their applications by Jun 28, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $400,000.00 to eligible and selected applicants.
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal governments (Federally recognized) For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Public and State controlled institutions of higher education.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for PAR 09 056

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

Improving Intervention Possibilities for Communication Disorders (PAR 09 056) is a National Institutes of Health grant opportunity from the National Institute on Deafness and Other Communication Disorders (NIDCD) that targets early, exploratory research meant to open up new ways to diagnose, prevent, or treat communication-related disorders in the future. It is positioned as a companion to another NIDCD announcement (PAR 09 057) that is more directly focused on developing interventions that are already closer to being proven effective. In contrast, this FOA is meant for projects that are still at a preliminary stage but are working toward breakthroughs in the underlying biology and methodology of the communication sciences, with a clear line of sight to eventual translational or clinical impact.

The main emphasis is on basic science that is explicitly tied to a real clinical or translational problem, even if the work itself is not yet ready for clinical testing. NIDCD is looking for studies that might be high-risk or uncertain in outcome, but that still have a realistic chance of producing new tools, concepts, methods, or experimental paradigms that could later become widely usable and cost-effective approaches for improving diagnosis, intervention, or treatment. The mission areas covered are broad and include hearing, balance, smell, taste, voice, speech, and language. A key boundary is that purely curiosity-driven basic biology, where there is no meaningful discussion of how it could enable future interventions, is considered out of scope.

This program explicitly does not support clinical and patient-oriented research under this announcement. In practical terms, applicants are expected to do foundational work (for example, uncovering biological mechanisms, developing models or measures, or creating enabling technologies) that could later support translational steps, but they should not propose human clinical trials or other patient-focused clinical studies as the core of the project within this FOA.

The funding uses the NIH R21/R33 phased innovation mechanism, which is designed to move projects from exploratory proof-of-concept to a more advanced development stage if early milestones are met. Applicants submit one integrated application that contains two clearly separated phases: an initial R21 phase followed by an R33 phase. The R21 portion supports early-stage, exploratory work and is milestone-driven; the R33 portion is intended to continue and expand the project once the R21 milestones demonstrate that the approach is feasible and still strongly justified. A required element of the application is a separate milestones statement that lays out measurable goals and explains why the results, if achieved, would have translational promise.

The award structure comes with clear limits. The total project period cannot exceed five years. The R21 phase can last up to two years with a cap of $275,000 in direct costs total, and no more than $150,000 in direct costs in any single R21 year. The R33 phase can extend up to four years (with the note that the four-year maximum assumes a one-year R21 component) and can request up to $1.5 million in direct costs total, capped at $400,000 in direct costs per year. The program requires a detailed, non-modular budget for both phases, meaning applicants should not use the modular budget format and instead must provide itemized budgets separately for R21 and R33.

In terms of application preparation, the R21/R33 Research Plan portion (PHS398 Items 2 through 5) is limited to 25 pages, and the milestones content must fit inside that same page limit. The announcement also allows multiple principal investigators (multiple PDs/PIs) if the project benefits from a team science approach. Applicants may submit more than one application as long as each is scientifically distinct. Resubmissions are permitted, but they must include an introduction that directly responds to the prior peer review critique. Renewals are not allowed under this FOA.

Eligibility is broad and includes many types of organizations: public and private institutions of higher education, nonprofits (including both 501(c)(3) and certain non-501(c)(3) entities), for-profit organizations (including small businesses and other for-profits), federally recognized tribal governments and other tribal organizations, U.S. territories or possessions, faith-based and community-based organizations, and even non-U.S. (foreign) organizations, among others. The FOA encourages applications from qualified investigators generally and continues NIH’s standard encouragement for individuals from underrepresented racial and ethnic groups and individuals with disabilities to serve as PDs/PIs.

Administrative details in the source listing indicate the FOA was posted December 19, 2008, with a closing date of June 28, 2010, and an archive date of July 29, 2010. The CFDA program number is 93.173 (Research Related to Deafness and Communication Disorders), and the opportunity does not require cost sharing or matching. Awards are contingent on the availability of funds; the listing includes an estimated total funding figure of $400,000, though actual awards would depend on appropriations and NIDCD priorities for that cycle.

Overall, this opportunity is best understood as a milestone-driven bridge between foundational discovery and later intervention development: it funds early basic-science advances that are still exploratory, but that are intentionally engineered to lead toward future diagnostic or therapeutic possibilities in the communication disorders field, without supporting clinical or patient-oriented research at this stage.

Frequently Asked Questions (FAQs)

What is the "Improving Intervention Possibilities for Communication Disorders (PAR 09 056)" opportunity?

It is a National Institutes of Health (NIH) funding opportunity from the National Institute on Deafness and Other Communication Disorders (NIDCD) that supports early, exploratory research aimed at opening new paths to diagnose, prevent, or treat communication-related disorders in the future.

What is the main goal of this funding opportunity?

The goal is to support basic science that is clearly tied to a real clinical or translational need in communication disorders, even if the work is not yet ready for clinical testing. The intent is to generate new tools, concepts, methods, models, measures, or experimental paradigms that could later enable practical, cost-effective approaches for diagnosis or intervention.

How is this FOA different from PAR 09 057?

PAR 09 056 is positioned as a companion to PAR 09 057. This FOA (PAR 09 056) focuses on earlier-stage, exploratory work that is still preliminary but has a clear line of sight to future translational or clinical impact. PAR 09 057 is described as being more directly focused on developing interventions that are closer to being proven effective.

What research areas or mission topics does NIDCD include under this program?

The covered mission areas are broad and include hearing, balance, smell, taste, voice, speech, and language.

Does this program support purely curiosity-driven basic biology?

No. Purely curiosity-driven basic biology is considered out of scope if the application does not meaningfully discuss how the work could enable future interventions (for example, future diagnosis, prevention, or treatment approaches).

Does this announcement allow clinical or patient-oriented research?

No. This program explicitly does not support clinical and patient-oriented research under this announcement. Applicants are expected to propose foundational work that could later support translational steps, but human clinical trials or other patient-focused clinical studies should not be the core of the project within this FOA.

What funding mechanism does this FOA use?

This FOA uses the NIH R21/R33 phased innovation mechanism. It is designed to move a project from exploratory proof-of-concept (R21) to a more advanced development stage (R33) if early milestones are met.

Do applicants submit separate applications for the R21 and the R33 phases?

No. Applicants submit one integrated application that contains two clearly separated phases: an initial R21 phase followed by an R33 phase.

How does a project transition from the R21 phase to the R33 phase?

The R21 portion is milestone-driven. The R33 portion is intended to continue and expand the project once the R21 milestones demonstrate that the approach is feasible and remains strongly justified.

Are milestones required in the application?

Yes. A required element is a separate milestones statement with measurable goals and an explanation of why the results, if achieved, would have translational promise.

What is the maximum total project period?

The total project period cannot exceed five years.

What is the maximum length and direct cost limit for the R21 phase?

The R21 phase can last up to two years with a cap of $275,000 in total direct costs, and no more than $150,000 in direct costs in any single R21 year.

What is the maximum length and direct cost limit for the R33 phase?

The R33 phase can extend up to four years (with the note that the four-year maximum assumes a one-year R21 component) and can request up to $1.5 million in total direct costs, capped at $400,000 in direct costs per year.

What type of budget format is required?

A detailed, non-modular budget is required for both phases. Applicants should not use the modular budget format and instead must provide itemized budgets separately for the R21 and the R33 phases.

Is there a page limit for the Research Plan?

Yes. The R21/R33 Research Plan portion (PHS398 Items 2 through 5) is limited to 25 pages, and the milestones content must fit within that same 25-page limit.

Are multiple principal investigators (multiple PDs/PIs) allowed?

Yes. The announcement allows multiple PDs/PIs if the project benefits from a team science approach.

Can an applicant submit more than one application?

Yes. Applicants may submit more than one application as long as each application is scientifically distinct.

Are resubmissions allowed?

Yes. Resubmissions are permitted, but they must include an introduction that directly responds to the prior peer review critique.

Are renewals allowed under this FOA?

No. Renewals are not allowed under this FOA.

What types of organizations are eligible to apply?

Eligibility is broad and includes public and private institutions of higher education, nonprofits (including 501(c)(3) and certain non-501(c)(3) organizations), for-profit organizations (including small businesses and other for-profits), federally recognized tribal governments and other tribal organizations, U.S. territories or possessions, faith-based and community-based organizations, and non-U.S. (foreign) organizations, among others.

Does the FOA encourage any particular investigator groups to apply as PDs/PIs?

It encourages applications from qualified investigators generally and follows NIH’s standard encouragement for individuals from underrepresented racial and ethnic groups and individuals with disabilities to serve as PDs/PIs.

When was the FOA posted, and what were the key dates listed?

The FOA was posted on December 19, 2008. The closing date listed is June 28, 2010, and the archive date is July 29, 2010.

What is the CFDA program number associated with this opportunity?

The CFDA program number is 93.173 (Research Related to Deafness and Communication Disorders).

Is cost sharing or matching required?

No. The opportunity does not require cost sharing or matching.

How much total funding was estimated for this opportunity?

The listing includes an estimated total funding figure of $400,000, with awards contingent on the availability of funds and dependent on appropriations and NIDCD priorities for that cycle.

What kind of projects is this opportunity best suited for?

It is best suited for milestone-driven projects that bridge foundational discovery and later intervention development: early basic-science advances that are exploratory (and may be high-risk) but are intentionally designed to lead toward future diagnostic or therapeutic possibilities in the communication disorders field, without conducting clinical or patient-oriented research at this stage.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Improving Interventions for Communication Disorders (R21/R33)

Previous opportunity: NIDDK Mentored Research Scientist Development Award (K01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 09 056

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 09 056) also looked into and applied for these:

Funding Opportunity
Improving Interventions for Communication Disorders (R21/R33) Apply for PAR 09 057

Funding Number: PAR 09 057
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
The Incidence and Etiology of Influenza Associated Pneumonia in Hospitalized Persons (U18) Apply for RFA IP 09 001

Funding Number: RFA IP 09 001
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,000,000
Advanced Neural Prosthetics Research and Development (SBIR U44) Apply for PA 09 064

Funding Number: PA 09 064
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Virologic evaluation of the modes of influenza virus transmission among humans (U01) Apply for RFA IP 09 003

Funding Number: RFA IP 09 003
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $7,000,000
Screening Targeted Populations to Interrupt On going Chains of Transmission with Enhanced Partner Notification The STOP Study Apply for RFA PS 09 004

Funding Number: RFA PS 09 004
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $166,666
Demonstration Project of Elective Adult Male Circumcision Conducted in Sexually Transmitted Disease (STD) Clinics in the United States Apply for RFA PS 09 005

Funding Number: RFA PS 09 005
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $80,000
Evaluating Locally Developed (Homegrown) HIV Prevention Interventions for African American and Hispanic/Latino Men Who Have Sex with Men (MSM) Apply for RFA PS 09 007

Funding Number: RFA PS 09 007
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $200,000
Operational Research to Improve the Implementation of Evidence Based Interventions that are Supported by the Diffusion of Effective Behavioral Interventions (DEBI) Project Apply for RFA PS 09 008

Funding Number: RFA PS 09 008
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $175,000
Optimization of Small Molecule Probes for the Nervous System (R21) Apply for RFA NS 09 003

Funding Number: RFA NS 09 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Career Development Award to Promote Diversity in Neuroscience Research (K01) Apply for PAR 09 065

Funding Number: PAR 09 065
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Partnerships for Complementary Alternative Medicine (CAM) Clinical Translational Research (PCCTR) (U19) Apply for PAR 09 066

Funding Number: PAR 09 066
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINR Career Transition Award (K22) Apply for PAR 09 067

Funding Number: PAR 09 067
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAID Research Scholar Development Award (K22) Apply for PAR 09 068

Funding Number: PAR 09 068
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Quick Trials for Imaging and Image Guided Interventions Exploratory Grants (R21) Apply for PAR 08 147

Funding Number: PAR 08 147
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Data Coordinating Center for Autism and Other Developmental Disabilities Research and Epidemiologic Studies (U10) Apply for RFA DD 09 002

Funding Number: RFA DD 09 002
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $700,000
NCI Transition Career Development Award to Promote Diversity (K22) Apply for PAR 09 069

Funding Number: PAR 09 069
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
TransACTION Prevention and Care Services for At Risk Mobile Populations Apply for 663 A 09 006

Funding Number: 663 A 09 006
Agency: Ethiopia USAID Addis Ababa
Category: Health
Funding Amount: $40,000,000
AHRQ Health Services Research Projects (R01) Apply for PA 09 070

Funding Number: PA 09 070
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
AHRQ Health Services Research Demonstration and Dissemination Grants (R18) Apply for PA 09 071

Funding Number: PA 09 071
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Chiropractic Demonstration Projects Apply for HRSA 09 108

Funding Number: HRSA 09 108
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 09 056", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.